Objectives: endothelin 1,2 plays a significant role in the process of ather
ogenesis and vascular wall injury. The nim of this study was to assess whet
her plasma endothelin 1,2 levels were elevated in patients with Inr ge or s
ymptomatic abdominal aortic aneurysms (AAAs).
Design: a prospective open study.
Materials and methods: plasma endothelin 1,2 levels were measured in 65 con
secutive patients with infrarenal aortic aneurysms and compared with the le
vels in 44 healthy volunteer controls. The data for abdominal aneurysm pati
ents was analysed in four subgroups: (i) small aneuryams (<5 cm), (ii) larg
e aneurysms (15 an), (iii) asymptomatic aneurysms and (iv) symptomatic aneu
rysms. Comparisons were made between endothelin 1,2 levels in aneurysm pati
ents and controls and betic,een the different aneurysm subgroups.
Results: a highly significant difference (p<0.0001) was found between aneur
ysm patients and controls. Patients with large aneurysms had significantly
higher levels than patients with small aneurysms (p<0.01). There was no sta
tistical difference in endothelin 1, 2 levels between symptomatic and asymp
tomatic patients; however, the highest levels were found in large, symptoma
tic aneurysms and the lowest in small, asymptomatic aneurysms.
Conclusions: plasma endothelin 1,2 is an endogenous marker of aneurysm diam
eter. Further studies are required to determine whether it relates to the r
ate of growth of aneurysms.